| Parameter . | TVD . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . | |
|---|---|---|---|---|---|---|---|---|
| OPCAB (n = 272) . | ONCABG (n = 155) . | |||||||
| Mortality (%) | 1.5 | 0.6 | 2.29 | 0.25–20.74 | 0.45 | 0.30 | 0.01–7.35 | 0.46 |
| Cerebrovascular accident (CVA) (%) | 0.4 | 3.2 | 0.11 | 0.01–0.95 | 0.04 | n/a | n/a | n/a |
| Myocardial infarction (%) | 0.7 | 1.9 | 0.35 | 0.03–3.47 | 0.37 | 0.30 | 0.02–3.94 | 0.36 |
| Bleeding (%) | 6.3 | 3.9 | 1.65 | 0.63–4.29 | 0.30 | 0.76 | 0.21–2.74 | 0.67 |
| Renal dysfunction (%) | 3.7 | 3.2 | 1.14 | 0.38–3.41 | 0.80 | 0.60 | 0.15–2.34 | 0.46 |
| Respiratory failure (%) | 1.1 | 3.9 | 0.27 | 0.03–2.30 | 0.23 | 0.22 | 0.02–2.09 | 0.19 |
| Pleural effusions/pneumothorax (%) | 0.7 | 5.2 | 0.12 | 0.01–1.04 | 0.06 | 0.11 | 0.01–0.94 | 0.04 |
| Sinus rhythm (%) | 95.1 | 95.5 | 0.91 | 0.31–2.68 | 0.87 | 1.76 | 0.51–6.10 | 0.37 |
| Atrial fibrillation (%) | 4.2 | 4.5 | 0.92 | 0.30–2.82 | 0.89 | 0.50 | 0.14–1.81 | 0.30 |
| MACCE (CVA/MI/mortality) (%) | 1.8 | 5.8 | 0.30 | 0.10–0.92 | 0.04 | 0.07 | 0.01–0.65 | 0.02 |
| Parameter . | TVD . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . | |
|---|---|---|---|---|---|---|---|---|
| OPCAB (n = 272) . | ONCABG (n = 155) . | |||||||
| Mortality (%) | 1.5 | 0.6 | 2.29 | 0.25–20.74 | 0.45 | 0.30 | 0.01–7.35 | 0.46 |
| Cerebrovascular accident (CVA) (%) | 0.4 | 3.2 | 0.11 | 0.01–0.95 | 0.04 | n/a | n/a | n/a |
| Myocardial infarction (%) | 0.7 | 1.9 | 0.35 | 0.03–3.47 | 0.37 | 0.30 | 0.02–3.94 | 0.36 |
| Bleeding (%) | 6.3 | 3.9 | 1.65 | 0.63–4.29 | 0.30 | 0.76 | 0.21–2.74 | 0.67 |
| Renal dysfunction (%) | 3.7 | 3.2 | 1.14 | 0.38–3.41 | 0.80 | 0.60 | 0.15–2.34 | 0.46 |
| Respiratory failure (%) | 1.1 | 3.9 | 0.27 | 0.03–2.30 | 0.23 | 0.22 | 0.02–2.09 | 0.19 |
| Pleural effusions/pneumothorax (%) | 0.7 | 5.2 | 0.12 | 0.01–1.04 | 0.06 | 0.11 | 0.01–0.94 | 0.04 |
| Sinus rhythm (%) | 95.1 | 95.5 | 0.91 | 0.31–2.68 | 0.87 | 1.76 | 0.51–6.10 | 0.37 |
| Atrial fibrillation (%) | 4.2 | 4.5 | 0.92 | 0.30–2.82 | 0.89 | 0.50 | 0.14–1.81 | 0.30 |
| MACCE (CVA/MI/mortality) (%) | 1.8 | 5.8 | 0.30 | 0.10–0.92 | 0.04 | 0.07 | 0.01–0.65 | 0.02 |
OR: odds ratio; CI 95%: confidence interval 95%; PA OR: propensity-adjusted OR; PA CI 95%: propensity-adjusted CI 95%; PA P-value: propensity-adjusted P-value; IABP: intra-aortic balloon pump; MACCE: major adverse cardiac and cerebrovascular events; n/a: not calculable (too small number of events).
| Parameter . | TVD . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . | |
|---|---|---|---|---|---|---|---|---|
| OPCAB (n = 272) . | ONCABG (n = 155) . | |||||||
| Mortality (%) | 1.5 | 0.6 | 2.29 | 0.25–20.74 | 0.45 | 0.30 | 0.01–7.35 | 0.46 |
| Cerebrovascular accident (CVA) (%) | 0.4 | 3.2 | 0.11 | 0.01–0.95 | 0.04 | n/a | n/a | n/a |
| Myocardial infarction (%) | 0.7 | 1.9 | 0.35 | 0.03–3.47 | 0.37 | 0.30 | 0.02–3.94 | 0.36 |
| Bleeding (%) | 6.3 | 3.9 | 1.65 | 0.63–4.29 | 0.30 | 0.76 | 0.21–2.74 | 0.67 |
| Renal dysfunction (%) | 3.7 | 3.2 | 1.14 | 0.38–3.41 | 0.80 | 0.60 | 0.15–2.34 | 0.46 |
| Respiratory failure (%) | 1.1 | 3.9 | 0.27 | 0.03–2.30 | 0.23 | 0.22 | 0.02–2.09 | 0.19 |
| Pleural effusions/pneumothorax (%) | 0.7 | 5.2 | 0.12 | 0.01–1.04 | 0.06 | 0.11 | 0.01–0.94 | 0.04 |
| Sinus rhythm (%) | 95.1 | 95.5 | 0.91 | 0.31–2.68 | 0.87 | 1.76 | 0.51–6.10 | 0.37 |
| Atrial fibrillation (%) | 4.2 | 4.5 | 0.92 | 0.30–2.82 | 0.89 | 0.50 | 0.14–1.81 | 0.30 |
| MACCE (CVA/MI/mortality) (%) | 1.8 | 5.8 | 0.30 | 0.10–0.92 | 0.04 | 0.07 | 0.01–0.65 | 0.02 |
| Parameter . | TVD . | OR . | CI 95% . | P-value . | PA OR . | PA CI 95% . | PA P-value . | |
|---|---|---|---|---|---|---|---|---|
| OPCAB (n = 272) . | ONCABG (n = 155) . | |||||||
| Mortality (%) | 1.5 | 0.6 | 2.29 | 0.25–20.74 | 0.45 | 0.30 | 0.01–7.35 | 0.46 |
| Cerebrovascular accident (CVA) (%) | 0.4 | 3.2 | 0.11 | 0.01–0.95 | 0.04 | n/a | n/a | n/a |
| Myocardial infarction (%) | 0.7 | 1.9 | 0.35 | 0.03–3.47 | 0.37 | 0.30 | 0.02–3.94 | 0.36 |
| Bleeding (%) | 6.3 | 3.9 | 1.65 | 0.63–4.29 | 0.30 | 0.76 | 0.21–2.74 | 0.67 |
| Renal dysfunction (%) | 3.7 | 3.2 | 1.14 | 0.38–3.41 | 0.80 | 0.60 | 0.15–2.34 | 0.46 |
| Respiratory failure (%) | 1.1 | 3.9 | 0.27 | 0.03–2.30 | 0.23 | 0.22 | 0.02–2.09 | 0.19 |
| Pleural effusions/pneumothorax (%) | 0.7 | 5.2 | 0.12 | 0.01–1.04 | 0.06 | 0.11 | 0.01–0.94 | 0.04 |
| Sinus rhythm (%) | 95.1 | 95.5 | 0.91 | 0.31–2.68 | 0.87 | 1.76 | 0.51–6.10 | 0.37 |
| Atrial fibrillation (%) | 4.2 | 4.5 | 0.92 | 0.30–2.82 | 0.89 | 0.50 | 0.14–1.81 | 0.30 |
| MACCE (CVA/MI/mortality) (%) | 1.8 | 5.8 | 0.30 | 0.10–0.92 | 0.04 | 0.07 | 0.01–0.65 | 0.02 |
OR: odds ratio; CI 95%: confidence interval 95%; PA OR: propensity-adjusted OR; PA CI 95%: propensity-adjusted CI 95%; PA P-value: propensity-adjusted P-value; IABP: intra-aortic balloon pump; MACCE: major adverse cardiac and cerebrovascular events; n/a: not calculable (too small number of events).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
